GSK Gets Accelerated FDA Approval For Tykerb
Tykerb is now indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer, that overexpresses the HER2 receptor for whom
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.
The proposed Sanofi-aventis-Minsheng joint venture will primarily focus on vitamins and mineral supplements (VMS). Recently, Sanofi-aventis had announced its planned acquisition of Chattem, a manufacturer and marketer of